Title
Does Fecal Microbiota Transplantation improve symptoms in adults with Irritable Bowel Syndrome?
Date of Award
2021
Degree Type
Selective Evidence-Based Medicine Review
Degree Name
Master of Science in Health Sciences - Physician Assistant
Department
Physician Assistant Studies
Abstract
OBJECTIVE: The objective of this selective EBM review is to determine whether or not fecal microbiota transplantation improves symptoms in adults with Irritable Bowel Syndrome.
STUDY DESIGN: A systematic review of two randomized controlled trials and one case series published in English and after 2009.
DATA SOURCES: All three studies were collected from peer-reviewed journals. Databases searched included Cochrane Collaboration and PubMed.
OUTCOMES MEASURED: Outcomes measured included Bristol Stool Form Scale and IBS Severity Scoring System (IBS-SSS).
RESULTS: Halkjær et al. revealed that the placebo FMT had a significant effect (p=0.008) at reducing IBS symptom severity in comparison to the FMT three months after transplantation. Johnsen et al. found that, at three months post-FMT, the treatment group showed a statistically significant effect (p=0.049) at reducing symptom severity. Mizuno et al. showed that six out of the 10 patients achieved a clinical improvement in stool form four weeks following FMT.
CONCLUSIONS: Out of the three articles reviewed, two found that FMT treatment group improved symptoms and one found that the control group given the placebo had a greater effect in improving symptoms.
Recommended Citation
Buskirk, Kristen, "Does Fecal Microbiota Transplantation improve symptoms in adults with Irritable Bowel Syndrome?" (2021). PCOM Physician Assistant Studies Student Scholarship. 598.
https://digitalcommons.pcom.edu/pa_systematic_reviews/598